|
US2096948A
(en)
|
1935-12-20 |
1937-10-26 |
Anchor Steel & Conveyor Co |
Conveyer system
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
ATE120454T1
(de)
|
1988-06-14 |
1995-04-15 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
IE63847B1
(en)
|
1989-05-05 |
1995-06-14 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
AU654811B2
(en)
|
1990-03-20 |
1994-11-24 |
Trustees Of Columbia University In The City Of New York, The |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
DE69133036T2
(de)
|
1990-11-09 |
2003-02-06 |
Stephen D. Gillies |
Cytokine immunokonjugate
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
DK0580737T3
(da)
|
1991-04-10 |
2004-11-01 |
Scripps Research Inst |
Heterodimere receptorbiblioteker ved anvendelse af phagemider
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
EP0733070A1
(en)
|
1993-12-08 |
1996-09-25 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
DE4440354A1
(de)
|
1994-11-11 |
1996-05-15 |
Hoechst Schering Agrevo Gmbh |
Kombinationen aus Phenylsulfonylharnstoff-Herbiziden und Safenern
|
|
US6696248B1
(en)
|
1995-08-18 |
2004-02-24 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
AU725609C
(en)
|
1995-08-18 |
2002-01-03 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
|
TWI335336B
(https=)
|
2000-02-10 |
2011-01-01 |
Abbott Gmbh & Co Kg |
|
|
US6897067B2
(en)
|
2000-11-03 |
2005-05-24 |
Regents Of The University Of Michigan |
Surface transfection and expression procedure
|
|
EP1340088B1
(en)
|
2000-11-17 |
2007-01-17 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
AU2002327164A1
(en)
|
2001-01-29 |
2002-12-09 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
AU2002318944A1
(en)
|
2001-08-01 |
2003-02-17 |
Coley Pharmaceutical Gmbh |
Methods and compositions relating to plasmacytoid dendritic cells
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
CA3077873A1
(en)
|
2002-03-20 |
2003-10-02 |
Catalina Marketing Corporation |
Targeted incentives based upon predicted behavior
|
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
|
AU2003289716A1
(en)
|
2002-09-12 |
2004-04-30 |
Incyte Corporation |
Molecules for diagnostics and therapeutics
|
|
US20070025992A1
(en)
*
|
2003-07-18 |
2007-02-01 |
Mochida Pharmaceutical Co., Ltd |
Monoclonal antibody against platelet membrane glycoprotein VI
|
|
US9208495B2
(en)
|
2003-10-06 |
2015-12-08 |
Yellowpages.Com Llc |
Methods and apparatuses for advertisement presentation
|
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
|
WO2006086586A2
(en)
|
2005-02-10 |
2006-08-17 |
Baylor Research Institute |
Anti-interferon alpha monoclonal antibodies and methods for use
|
|
WO2006124269A2
(en)
*
|
2005-05-16 |
2006-11-23 |
Amgen Fremont Inc. |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
|
AU2012244391B2
(en)
*
|
2005-12-20 |
2014-09-11 |
Sbi Biotech Co., Ltd. |
Anti-ILT7 antibody
|
|
HRP20130494T1
(en)
|
2005-12-20 |
2013-08-31 |
Sbi Biotech Co., Ltd. |
Anti-ilt7 antibody
|
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
|
WO2007130493A2
(en)
|
2006-05-03 |
2007-11-15 |
Regents Of The University Of Colorado |
Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
|
|
US7781306B2
(en)
|
2007-06-20 |
2010-08-24 |
Semiconductor Energy Laboratory Co., Ltd. |
Semiconductor substrate and method for manufacturing the same
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
US20110311558A1
(en)
|
2008-12-01 |
2011-12-22 |
The Board Of Regents Of The University Of Texas System |
Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases
|
|
US20120251546A1
(en)
|
2009-09-03 |
2012-10-04 |
Medimmune Llc |
Type 1 inteferon diagnostic
|
|
CA2780221A1
(en)
|
2009-11-04 |
2011-05-12 |
Fabrus Llc |
Methods for affinity maturation-based antibody optimization
|
|
AU2012249601A1
(en)
|
2011-04-26 |
2013-05-09 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
|
PT3415619T
(pt)
|
2011-04-28 |
2021-03-22 |
Univ Leland Stanford Junior |
Identificação de polinucleótidos associados a uma amostra
|
|
US9427464B2
(en)
|
2011-11-22 |
2016-08-30 |
Chiome Bioscience Inc. |
Anti-human TROP-2 antibody having an antitumor activity in vivo
|
|
EP3431504B1
(en)
*
|
2012-01-31 |
2021-03-24 |
SBI Biotech Co., Ltd. |
Anti-phospholipase d4 antibody
|
|
US8605807B1
(en)
|
2012-05-22 |
2013-12-10 |
Nigel Iain Stuart Macrae |
Communicating distinct data over a single frequency using multiple linear polarized signals
|
|
EP2916827B1
(en)
*
|
2012-11-08 |
2020-06-10 |
Clearside Biomedical Inc. |
Methods for the treatment of ocular disease in human subjects
|
|
US9114438B2
(en)
|
2013-05-21 |
2015-08-25 |
Applied Materials, Inc. |
Copper residue chamber clean
|
|
SG11201701529YA
(en)
|
2014-08-29 |
2017-03-30 |
Sorrento Therapeutics Inc |
Antibody therapeutics that bind oprf and oprl
|
|
RU2756109C2
(ru)
|
2016-03-10 |
2021-09-28 |
Виела Байо, Инк. |
Связывающие ilt7 молекулы и способы их применения
|
|
WO2021113702A1
(en)
|
2019-12-06 |
2021-06-10 |
Viela Bio, Inc. |
Methods of treatment using ilt7 binding proteins
|
|
IL308132A
(en)
|
2021-05-04 |
2023-12-01 |
Viela Bio Inc |
Methods of treatment of autoimmune disorders using ilt7 binding proteins
|